tailieunhanh - Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

Knowledge about tumour gene mutation status is essential for the treatment of increasing numbers of cancer patients, and testing quality has a major impact on treatment response and cost. In 2012, 4,629 tests for BRAF were performed in France, in patients with melanomas. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN